Nofel Mahmmod

Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

Mirthe E. van der Valk, Marie‐Josée J. Mangen, Max Leenders et al. · Gut · 2012 · 498 citations · Full text

Pharmacy, Pharmacoeconomics, Surgery +17

Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial

Marin J. de Jong, Andrea E. van der Meulen‐de Jong, Mariëlle Romberg‐Camps et al. · The Lancet · 2017 · 359 citations · Full text

Medicine, Internal Medicine, Surgery +9

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

Cyriel Y. Ponsioen, E. Joline de Groof, Emma J. Eshuis et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 356 citations

Medicine, Clinical Sciences, Surgery +12

Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease

Marieke J. H. Coenen, Dirk J. de Jong, Corine J. van Marrewijk et al. · Gastroenterology · 2015 · 197 citations · Full text

Medicine, Hematology, Pharmacology +14

Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial

Toer Stevens, Maria L. Haasnoot, Geert D’Haens et al. · ˜The œLancet. Gastroenterology & hepatology · 2020 · 179 citations

Medicine, Surgery, Gastroenterology +10